InsiderTrades

Form 4 for SNDX Syndax Pharmaceuticals Inc

Accepted 2022-12-02 00:00:00 ET · period of report 2022-12-01 · accession 0001562180-22-008017 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-02 2022-12-01+ SNDX Ordentlich Peter CSO M - OptEx $6.38 +25.0K 4,037 New +$159.4K
DM 2022-12-02 2022-12-01+ SNDX Ordentlich Peter CSO S - Sale+OE $25.04 -25.0K 265 -99% -$625.9K
DM 2022-12-02 2022-12-01+ SNDX Ordentlich Peter CSO M - OptEx $0.00 -25.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-01 M A 4,028 $6.38 4,293 D — —
2 Common Common Stock 2022-12-02 M A 17,200 $6.38 17,465 D — —
3 Common Common Stock 2022-12-02 S D 17,200 $25.05 265 D — — (F3) The sale prices ranged from $25.00 to $25.19.
4 Common Common Stock 2022-12-01 S D 4,028 $25.01 265 D — — (F2) The sale prices ranged from $25.00 to $25.03.
5 Common Common Stock 2022-12-01 M A 3,772 $6.35 4,037 D — —
6 Common Common Stock 2022-12-01 S D 3,772 $25.01 265 D — — (F2) The sale prices ranged from $25.00 to $25.03.
7 Derivative Stock Options (Right to buy) 2022-12-02 M D 17,200 $0.00 0 D $6.38 · — to 2029-02-06 17,200 Common Stock (F4) This option is fully vested.
8 Derivative Stock Options (Right to buy) 2022-12-01 M D 4,028 $0.00 0 D $6.38 · — to 2029-02-06 4,028 Common Stock (F4) This option is fully vested.
9 Derivative Stock Options (Right to buy) 2022-12-01 M D 3,772 $0.00 0 D $6.35 · — to 2024-12-18 3,772 Common Stock (F4) This option is fully vested.